Dark

TBPH
Theravance Biopharma, Inc.
stock NASDAQ

At Close

Sep 11, 2026 3:59:56 PM EDT

17.02USD0.000%(0.00)420,492

0.00Bid 0.00Ask 0.00Spread

Pre-market

0.00USD-100.000%(-17.02)0

After-hours

Sep 10, 2026 4:00:30 PM EDT

17.02USD0.000%(0.00)0

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

883.66M

CEO

Rick Winningham

Headquarters

George Town, Grand Cayman, Cayman Islands

Industry

Biotechnology

CORT CPIX COLL XLV

TBPH Stats

Avg. Vol. 10 Day

403,540

Avg. Vol. 30 Day

479,735

Employees

340

Market Cap

883,657,193

Shares Out.

51,918,754

On/Off Exchange

55%/45%

6 Month Beta

0.21

1 Year Beta

0.53

2 Year Beta

0.55

3 Year Beta

0.53

52 Week Low

13.08

52 Week High

21.03

SMA50

16.95

SMA200

17.27

1 Week

-0.35%

1 Month

+0.59%

3 Month

+3.21%

6 Month

+23.24%

1 Year

+24.23%

2 Year

+110.12%

5 Year

+101.18%

Profile

theravance biopharma is a biopharmaceutical company with one approved product, vibativ® (telavancin), that was discovered and developed internally, a pipeline of internally discovered product candidates and strategic collaborations with pharmaceutical companies.

TBPH Stock Summary

Theravance Biopharma, Inc. (NASDAQ:TBPH) stock price today is $17.02, and today's volume is 420,492. TBPH is down 0.000% today. The 30 day average volume is 479,735. TBPH market cap is 883.66M with 51,918,754 shares outstanding.